$GTVH News: Golden Triangle Ventures, Inc. Announces the

New Post Public Reply Private Reply Replies (0) Message Board
Lee Adams
131
$GTVH News: Golden Triangle Ventures, Inc. Announces the 100% Acquisition of HyFrontier Technologies, Inc.

LAS VEGAS, NV, May 19, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Golden Triangle Ventures, Inc. (OTC PINK:GTVH) has executed a formal purchase agreement with Robert DuBose, CEO of HyFrontier Technologies, to purchase the remaining 49% of HyFrontier Technologies, Inc., giving Golden Triangle Ventures 100% ownership of the Technology Company.

HyFrontier Technologies, Inc. owns a patent-pending process and device technology called "HyGrO", which is a molecular Hydrogen and Oxygen delivery system for Agriculture. The Company has a mission to improve global crop production efficiency by producing Hydrogen and Oxygen directly in the water stream. This technology can be used on any species of plant life in nearly any grow medium. Additionally, the system can be retrofitted to wellheads for large-scale agricultural projects, indoor grow operations, and small farms or utilized for a multitude of residential home and garden applications.

In-house testing has shown evidence that Hydrogen is capable of increasing crop yields by up to 25%, and in many circumstances, a larger amount. Bigger, and more in-depth root systems and better overall plant health were also observed by watering plants with the HyGrO unit. Universities and multiple 3rd party testing facilities are currently working to validate the HyGrO technology, and all preliminary results are extremely positive. To push the development and commercialization of the technology, management has now moved the Company headquarters from Colorado to Florida and the team involved has transitioned its operations into a 7800 sq. ft. state-of-the-art manufacturing facility. The Company recently executed a 3-year lease with an option to purchase the entire 24,000 sq. ft. building which will help the business in achieving its ultimate goal of commercializing this technology to the world.

Steffan Dalsgaard, CEO of Golden Triangle Ventures, states, "This acquisition has been something that Bo and I have been working towards for quite some time and we are both incredibly happy to have this executed. We knew that completing this agreement would show the world that we are both fully committed to our shareholders and the brilliant future of this revolutionary company. I have watched Bo and his team in Florida make a myriad of significant advancements of this technology since we started working together. In just the past few weeks, there have been developments that could significantly benefit the entire agricultural industry which have only further bolstered my confidence on the trajectory and path forward. Our team is absolutely thrilled to have Bo as an official partner in our Company and we are honored to have such a brilliant and genuine person as a team member and true stakeholder in our vision to build this division into something beautiful for everyone involved."

Robert “Bo” DuBose, CEO of HyFrontier Technologies, states, "In business, I have always been enamored with those whom I can confirm in my soul and have traits that reveal the 'it' factor. These are the types who become great leaders in their respective fields of endeavor. They always, no matter the circumstances, do the right thing for everyone involved - PERIOD - whether it involves their professional life or personal relationships. Great leaders are the best listeners, act with God-given principles, and do their absolute best to deliver on promises made. I've come to know Steffan very well, have purposely tested him, both professionally and personally, and can say he exhibits these traits. I'm so very honored to officially join the GTV Board as an equal shareholder and join him in leading the Technology Division. Finally, I want to say from the bottom of my heart to the GTV family, shareholders, as well as our present and future customers; HyFrontier Technologies is in great hands. Steffan, myself and the entire HFT team look forward to making this amazing Company into one that we believe can change the world!"

HyFrontier Technologies, Inc. Information

www.HyFrontier.com

About Golden Triangle Ventures, Inc.

Golden Triangle Ventures, Inc. (GTV) is a multifaceted consulting Company pursuing ventures in the Health, Entertainment, and Technology industries, with many additional projects being developed that provide synergistic values to these divisions. The Company aims to purchase, acquire, and/or joint venture with established entities that management can help assist and develop into unique opportunities. Additionally, GTV provides a professional corporate representation service to different companies in these sectors while consulting on a variety of business development objectives. The goods and services represented are driven by innovators who have passion and commitment to these marketplaces. The Company plans to utilize relationships and create a platform for new and existing businesses to strengthen their products and/or services. The three points of the Golden Triangle exclusively represents these three sectors in which the Company aims to do business in.

www.GoldenTriangleInc.com

HEALTH DIVISION

Global Health Services is a wholly owned subsidiary of Golden Triangle Ventures (operating under its Health Division). Dedicated to the promotion of well-being and natural wellness, the Company currently does business in the Medical PPE space as well as the Industrial Hemp/CBD industry. Additionally, the Company has a vision to promote, market, and generate sales for a myriad of products and services which include a full retail line of high-end, all-natural, health, wellness, and beauty products. To help achieve this vision, Global Health Services is in the process of further developing an extensive online portal that will support the multiple verticals under the company and provide a one-stop-shop for all of the Company's products and services. Moreover, to support overarching business goals, senior management tirelessly works on acquiring and building an array of profitable assets and projects.

www.GTVHealth.com

ENTERTAINMENT DIVISION

Lavish Entertainment (EpicRaves) is a wholly owned subsidiary of Golden Triangle Ventures under its Entertainment Division. Operating out of Las Vegas, Nevada, the Company started doing business in 2017 and was established with a vision of becoming a nationally recognized concert production Company. The Company currently has more than 30,000 national followers and nearly 100 team members which have helped the Company successfully organize some of the most exciting Electronic Dance Music concerts in Las Vegas. Lavish Entertainment is currently Doing Business as (DBA) "EpicRaves" which will eventually become a wholly owned subsidiary of Lavish Entertainment as the Company expands its business into a variety of other forms of Entertainment.

www.EpicRaves.com

TECHNOLOGY DIVISION

HyFrontier Technologies is a wholly owned subsidiary of Golden Triangle Ventures under its Technology Division. The Company owns a patent-pending process and device technology called "HyGrO", which is a molecular Hydrogen and Oxygen delivery system for Agriculture. Golden Triangle Ventures, Inc. is assisting the Company in commercializing the HyGrO unit for farm and home use in markets across the globe. HyFrontier Technologies, Inc. has a mission to improve global crop production efficiency by producing Hydrogen and Oxygen directly in the water stream. This technology can be used on any species of plant life in nearly any grow medium. Additionally, the system can be retrofitted to wellheads for large-scale agricultural projects, indoor grow operations and small farms or utilized for a multitude of residential home and garden applications. In-house testing has shown evidence that Hydrogen is capable of increasing crop yields by up to 25%, and in many circumstances, a much higher amount. Larger root systems and better overall plant health were also observed by watering plants with the HyGrO unit. Universities and multiple 3rd party testing facilities are currently working to validate the HyGrO technology, and all preliminary results are extremely positive. To push the development and commercialization of the technology, management is now in the process of moving the Company headquarters from Colorado to Florida which will transition its operations into a 7800 sq. ft. state-of-the-art manufacturing facility. The Company recently executed a 3-year lease with an option to purchase the entire 24,000 sq. ft. building which will help the business in achieving its ultimate goal of commercializing this technology to the world.

www.HyFrontier.com

FOOD & WINE

Napa Wine Brands is a wholly owned subsidiary of Golden Triangle Ventures which is a synergistic business with a mission of providing a world-class portfolio of unique brands which are all birthed from Napa Valley and Sonoma Valley in the heart of California’s Wine Country. The Company has a commitment to manufacture and distribute specialty wines, foods, and unique items while tapping into an array of hidden markets in the food and beverage industry. With extensive resources and award-winning products, Napa Wine Brands aims to develop some of the most desirable products in today’s market. Originated by some of the most profound experts in Napa Valley, the Company’s vision is to broaden the horizon of a traditional Food and Wine Company by creating a platform different than anything seen in the Northern Hemisphere. Napa Wine Brands has an array of fully developed products and services that provide value to the other divisions under Golden Triangle Ventures. The Company is now preparing the launch of several brands, products, and services that are market-ready and will immediately turn into cash-positive businesses. Golden Triangle Ventures will provide a full support system and assist management of Napa Wine Brands in growing this Company into another fun, exciting, and profitable division of Golden Triangle Ventures.

www.NapaWineBrands.com

FORWARD-LOOKING INFORMATION

Certain information set forth in this press release contains "forward-looking information", including "future-oriented financial information" and "financial outlook", under applicable securities laws (collectively referred to herein as forward-looking statements). Except for statements of historical fact, the information contained herein constitutes forward-looking statements and includes, but is not limited to, the (i) projected financial performance of the Company; (ii) completion of, and the use of proceeds from, the sale of the shares being offered hereunder; (iii) the expected development of the Company's business, projects, and joint ventures; (iv) execution of the Company's vision and growth strategy, including with respect to future M&A activity and global growth; (v) sources and availability of third-party financing for the Company's projects; (vi) completion of the Company's projects that are currently underway, in development or otherwise under consideration; (vi) renewal of the Company's current customer, supplier and other material agreements; and (vii) future liquidity, working capital, and capital requirements. Forward-looking statements are provided to allow potential investors the opportunity to understand management's beliefs and opinions in respect of the future so that they may use such beliefs and opinions as one factor in evaluating an investment. These statements are not guarantees of future performance and undue reliance should not be placed on them. Such forward-looking statements necessarily involve known and unknown risks and uncertainties, which may cause actual performance and financial results in future periods to differ materially from any projections of future performance or result expressed or implied by such forward-looking statements. Although forward-looking statements contained in this presentation are based upon what management of the Company believes are reasonable assumptions, there can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. The Company undertakes no obligation to update forward-looking statements if circumstances or management's estimates or opinions should change except as required by applicable securities laws. The reader is cautioned not to place undue reliance on forward-looking statements. The Securities and Exchange Commission ("SEC" has provided guidance to issuers regarding the use of social media to disclose material non-public information. In this regard, investors and others should note that we announce material financial information on our investor relations company website, www.TheWaypointRefinery.com, in addition to SEC filings, press releases, public conference calls and webcasts. We use these channels as well as social media to communicate with the public about our company, our services, and other issues. It is possible that the information we post on social media could be deemed to be material information. Therefore, in light of the SEC's guidance, we encourage investors, the media, and others interested in our company to review the information we post on the following U.S. social media channels:

Twitter: www.twitter.com/GTV_Inc

The Waypoint Refinery, LLC

www.thewaypointrefinery.com
Twitter:@waypointthe

CONTACT INFORMATION

Golden Triangle Ventures, Inc.

3035 E Patrick Ln. #15
Las Vegas, NV 89120
info@GoldenTriangleInc.com
1-800-469-2614
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fosun Pharma Hits the Buyback Button: What's Next?

Updated Category News Views 0

Fosun Pharma's Bold Move Well, if this isn't Fosun Pharma making some noise! Announcing an H-share repurchase plan worth up to HK$1 billion is like setting off fireworks amidst any investor's evening. They're hollering to the market, 'We see value, and we're doubling down on it.' Crunching the Numbers In the first half of 2026, Fosun Pharma's numbers weren't just a flash...

Continue Reading
Harbour BioMed Joins Stock Connect, Boosts Investor Access

Updated Category News Views 1

The Big Leap: Harbour BioMed Joins Stock Connect Well, if this ain't something to get excited about—Harbour BioMed just snagged a spot on the Stock Connect roster. This step isn't just ceremonial. We're talking about real access for mainland Chinese investors to dive directly into the shares of Harbour BioMed (HKEX: 02142.HK) through the Shanghai-Hong Kong and...

Continue Reading
Bad Bunny Super Bowl Halftime Show Sweeps 7 Emmy Wins

Updated Category News Views 3

An Unprecedented Performance: A Halftime Show for the Ages Hold onto your hats, folks—Bad Bunny and his Super Bowl LX Halftime Show have taken home a jaw-dropping seven Emmys at the 78th Emmy Awards. This is uncharted territory for any Super Bowl Halftime Show. Never before has a halftime spectacle swept the Emmys like this. We’re talking about categories such as...

Continue Reading
Asia-Pacific Media Forum Eyes Future Growth Strategies

Updated Category News Views 2

Media Heavyweights Converge in Shenzhen Picture this: Over 400 media moguls from the Asia-Pacific region, huddled together in Shenzhen under that blazing September sun. What for? They're on a mission, inspecting China's shifting landscape, hunting down fresh growth avenues in the Guangdong-Hong Kong-Macao Greater Bay Area. It kicks off within the walls of the Asia-Pacific...

Continue Reading
Aroa Biosurgery Reports Low Infection Rates: A Milestone

Updated Category News Views 1

Peer-Reviewed Study: Aroa's Myriad Shows Low Infection Rates Seems like the folks at Aroa Biosurgery have got something solid to brag about in the world of complex soft tissue reconstruction. The company just released interim results from their massive MASTRR Registry study, and the numbers are looking pretty darn promising. We're talking about a 411-patient analysis...

Continue Reading
EyePoint Stumbles: Legal Eagles Circle Post-Trial Flop

Updated Category News Views 2

EyePoint Slips on Clinical Banana Peel Well, if EyePoint was aiming for a splash, they sure got it—just not the kind they were hoping for. News dropped like a lead balloon when EyePoint announced their Phase 3 DURAVYU trial results for wet age-related macular degeneration, revealing they missed their primary endpoint. And what did that mean for their stock? A death...

Continue Reading
Mermaid Folklore Meets Revolution in New Short Film

Updated Category News Views 2

A Sea Haunting Like No Other Ever feel like history's forgotten tales deserve a fresh spin? Well, this one's shaking it up! Hoyt Dwyer, an Atlanta filmmaker, flips the script on a lesser-known bit from the American Revolution. Yeah, we're talking about Hessian soldiers and sirens here. Just hang on to your hats because this ain't your typical historical retelling. A...

Continue Reading
Creality Rolls Out K3, SPARKX i8 at IFA 2026

Updated Category News Views 12

Creality Struts Its Stuff at IFA 2026 You wouldn't guess 3D printing had anything left to dazzle us with, but Creality has sure put those notions to rest at the IFA 2026 in Berlin. They're rolling out the big guns with fresh tech that pushes both efficiency and sustainability—two big buzzwords these days—and ties a neat little bow on their innovative streak....

Continue Reading
Ice-Rock Avalanches: Future Risks and Urgent Lessons

Updated Category News Views 1

Mounting Threats in Mountain Chains That nightmare on August 26 at Mount Langtang Lirung in Nepal—where an ice-rock avalanche triggered a catastrophic mudslide—brought a harsh reminder that these mountains are cracking wide open. With 31 dead and over 500 souls still unaccounted for, it's a chilling warning about how vulnerable high-altitude regions have become. A...

Continue Reading

Top 5 Most Recently Viewed Articles

Aterian Prepares for Upcoming Earnings Call This Quarter

Updated Category News Views 99

Aterian's Upcoming Financial Results Announcement Aterian, Inc. (Nasdaq: ATER), a prominent player in the consumer products sector, is gearing up to reveal its financial performance for the second quarter. Scheduled for Wednesday in the coming week, this announcement will take place after market closure, providing investors with valuable insights into the company’s...

Continue Reading
Analyzing RTX: Trends in Short Interest and Market Sentiment

Updated Category News Views 176

Understanding RTX's Recent Market Movements RTX Corp has seen a notable shift in its market dynamics recently. The company's short interest, defined as the number of shares sold short but not yet covered, has decreased by 7.63% since the last reporting period. Currently, there are approximately 16.18 million shares sold short, equating to 1.21% of all shares available for...

Continue Reading
Celebrate Christmas Spirit with Personalized PrayerSongs

Updated Category News Views 156

Celebrate the Joy of Christmas with PrayerSong Bring Love Into Your Home with a PrayerSong for Your Family and Friends When the holiday season arrives, the focus shifts beyond material gifts. Instead, it’s about nurturing connections filled with love, faith, and meaningful moments. This Christmas, PrayerSong provides families with a unique opportunity to honor loved...

Continue Reading
Understanding the Short Selling Landscape of Analog Devices

Updated Category News Views 153

Analyzing Short Interest for Analog Devices As investors navigate the ever-changing stock market, understanding short interest can provide valuable insights into market sentiment regarding Analog Devices (NYSE: ADI). Recently, it was reported that Analog Devices has seen a notable increase of 4.11% in its short percent of float. Currently, there are approximately 7.52...

Continue Reading
Future of Clinical Trials: Exploring Market Growth to USD 85.37 Billion

Updated Category News Views 71

Understanding Clinical Trials and Their Importance Clinical trials serve as a fundamental pillar in advancing medical knowledge and enhancing patient care. These trials encompass a detailed and thorough process involving participant recruitment, intervention administration, data collection, and result analysis. The outcomes produced from clinical trials play a crucial...

Continue Reading